Inventor profile of:

Andreas Vegge

City:

Frederiksberg

Country:

Denmark

Published Applications:

12

Last publication date:

2024-12-26

Top Assignees for applications by Andreas Vegge

The entities that hold a legal rights for patent applications filed by inventor Vegge Andreas:

Recent patent applications by Vegge Andreas

Andreas Vegge from Frederiksberg, DK has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-12-26
US20240425837A1
Chemistry; metallurgy

HIGHLY POTENT ISVD COMPOUNDS CAPABLE OF SUBSTITUTING FOR FVIII(A)

#2 | 2024-02-29
US20240067944A1
Chemistry; metallurgy

Highly potent ISVD compounds capable of substituting for FVIII(A)

#3 | 2023-03-23
US20230087952A1
Human necessities

Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid

#4 | 2023-01-05
US20230000949A1
Human necessities

SOLID COMPOSITIONS COMPRISING A PCSK9 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

#5 | 2022-12-15
US20220395559A1
Human necessities

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

#6 | 2022-10-13
US20220323544A1
Human necessities

SOLID COMPOSITIONS COMPRISING AN EGF(A) DERIVATIVE AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

#7 | 2022-09-08
US20220280611A1
Human necessities

SOLID COMPOSITION COMPRISING A PYY COMPOUND AND A SALT OF N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

#8 | 2022-08-25
US20220265777A1
Human necessities

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

#9 | 2022-01-20
US20220016216A1
Human necessities

SOLID GLP-1 DERIVATIVE COMPOSITIONS FOR ORAL ADMINISTRATION

#10 | 2021-08-05
US20210236601A1
Human necessities

Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid

#11 | 2020-08-06
US20200246545A1
Human necessities

Systems and methods for liquid injection

#12 | 2020-05-14
US20200147179A1
Human necessities

Solid glp-1 derivative compositions for oral administration

InventorID:

2728136 ⎘